R 
Recordati Industria Chimica e Farmaceutica SpA REC.MI · EUR
Health Care · Borsa Italiana · 🇮🇹 Italy
53.10
-0.28%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in EUR, from our data supplier.
Revenue
€2.62bn
FY2016FY2025
Net income
€443.6m
FY2016FY2025
Free cash flow
€511.8m
FY2016FY2025
Shareholders' equity
€1.92bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | €2.62bn | €2.34bn | €2.08bn | €1.85bn | €1.58bn | €1.45bn | €1.48bn | €1.35bn | €1.29bn | €1.15bn |
| Gross profit | €1.79bn | €1.60bn | €1.42bn | €1.29bn | €1.15bn | €1.04bn | €1.04bn | €956.7m | €905.4m | €793.0m |
| Research and development | €341.0m | €286.0m | €255.7m | €220.1m | €166.1m | €146.2m | €129.7m | €109.7m | €100.3m | €83.7m |
| Operating income | €719.7m | €638.9m | €558.0m | €437.3m | €490.2m | €469.0m | €465.3m | €442.2m | €406.5m | €327.4m |
| Net income | €443.6m | €416.5m | €389.2m | €312.3m | €386.0m | €355.0m | €368.8m | €312.4m | €288.8m | €237.4m |
| Diluted earnings per share | 2.12 | 1.99 | 1.86 | 1.49 | 1.88 | 1.72 | 1.79 | 1.53 | 1.39 | 1.16 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | €5.25bn | €5.13bn | €4.21bn | €4.00bn | €2.82bn | €2.71bn | €2.81bn | €2.16bn | €2.06bn | €1.56bn |
| Cash and short-term investments | €428.8m | €322.4m | €221.8m | €284.7m | €244.6m | €188.2m | €187.9m | €198.0m | €302.1m | €138.5m |
| Total liabilities | €3.33bn | €3.26bn | €2.52bn | €2.45bn | €1.43bn | €1.44bn | €1.61bn | €1.20bn | €1.03bn | €656.8m |
| Debt | €337.2m | €2.48bn | €1.81bn | €1.72bn | €992.2m | €1.06bn | €1.10bn | €788.1m | €680.7m | €349.8m |
| Shareholders' equity | €1.92bn | €1.88bn | €1.69bn | €1.55bn | €1.38bn | €1.28bn | €1.20bn | €963.4m | €1.03bn | €903.8m |
| Shares outstanding | 209m | 209m | 209m | 209m | 206m | 206m | 206m | 204m | 207m | 206m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | €596.9m | €569.9m | €485.3m | €461.7m | €491.6m | €403.6m | €334.0m | €371.6m | €272.7m | €255.4m |
| Capital spending | −€85.1m | −€36.6m | −€383.3m | −€96.3m | −€87.4m | −€131.7m | −€458.4m | −€84.6m | −€320.7m | −€36.9m |
| Free cash flow | €511.8m | €533.3m | €102.1m | €365.4m | €404.3m | €271.9m | −€124.4m | €287.0m | −€48.0m | €218.5m |
| Dividends paid | −€267.6m | −€253.7m | −€246.0m | −€230.6m | −€216.7m | −€212.7m | −€190.9m | −€178.9m | −€159.6m | −€133.7m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | €697.4m | €713.4m | €662.2m | €632.3m | €643.9m | €680.0m | €598.5m | €557.4m |
| Gross profit | €498.0m | €510.8m | €472.6m | €432.4m | €423.9m | €458.8m | €413.4m | €385.1m |
| Operating income | €203.8m | €231.7m | €223.1m | €165.6m | €135.3m | €195.8m | €134.8m | €165.6m |
| Net income | €116.6m | €153.1m | €117.3m | €110.2m | €91.1m | €125.0m | €78.1m | €113.0m |
| Diluted earnings per share | 0.56 | 0.73 | 0.56 | 0.53 | 0.44 | 0.60 | 0.37 | 0.54 |
| Cash from operations | €217.0m | €102.0m | €172.0m | €152.0m | €107.0m | €164.0m | €115.0m | €187.0m |
| Capital spending | −€61.0m | −€11.0m | −€27.0m | −€14.0m | −€34.0m | −€8.0m | −€14.0m | −€16.0m |
| Free cash flow | €156.0m | €91.0m | €145.0m | €138.0m | €73.0m | €156.0m | €101.0m | €171.0m |
| Total assets | €5.37bn | €5.33bn | €5.25bn | €5.30bn | €5.18bn | €5.17bn | €5.13bn | €4.20bn |
| Cash and short-term investments | — | €380.5m | €428.8m | €471.5m | €341.6m | €333.0m | €322.4m | €235.0m |
| Debt | — | €609.9m | €337.2m | €328.7m | €80.9m | €315.0m | €316.3m | €292.8m |
| Shareholders' equity | €2.13bn | €2.06bn | €1.92bn | €1.93bn | €1.87bn | €1.98bn | €1.88bn | €1.88bn |
Financial ratios
Data as of 7 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 68.3% | 68.3% | 68.3% | 69.4% | 72.9% | 71.9% |
| Operating margin | 26.0% | 26.8% | 27.2% | 23.4% | 30.4% | 32.7% |
| Net margin | 16.9% | 17.8% | 18.7% | 16.9% | 24.4% | 24.5% |
| Return on equity | 23.1% | 22.2% | 23.1% | 20.2% | 27.9% | 27.8% |
| Return on assets | 8.4% | 8.1% | 9.2% | 7.8% | 13.7% | 13.1% |
| Free cash flow yield | 6.2% | 5.5% | 7.8% | 5.0% | 5.3% | 4.9% |
| Revenue growth | 11.8% | 12.4% | 12.4% | 17.3% | 9.1% | -2.2% |
| Earnings growth | 6.5% | 7.0% | 24.6% | -19.1% | 8.7% | -3.8% |
| Current ratio | 1.59x | 1.61x | 1.20x | 1.28x | 1.36x | 1.34x |
| Debt to equity | 0.18x | 0.17x | 0.07x | 0.25x | 0.17x | 0.22x |
| Equity ratio | 36.6% | 36.6% | 40.1% | 38.7% | 49.1% | 47.1% |
| Interest coverage | 6.85x | 7.71x | 7.60x | 13.42x | 27.41x | 27.03x |
| R&D as a share of sales | 13.0% | 12.2% | 12.3% | 11.9% | 10.5% | 10.1% |
| Buybacks as a share of market value | -0.1% | 0.2% | -0.1% | -1.6% | 0.3% | -0.2% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 12.2% | 12.6% | 9.6% |
| Operating income | 18.1% | 8.9% | 10.0% |
| Net income | 12.4% | 4.6% | 8.4% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 68.3% | 68.5% | 69.5% | 69.6% |
| Operating margin | 27.4% | 26.5% | 27.8% | 28.7% |
| Net margin | 17.3% | 17.6% | 19.3% | 20.3% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 22.9 | 25.4 | 26.2 | 25.9 | 30.1 | 26.3 | 21.0 | 19.8 | 26.6 | 23.3 |
| Price to sales | 3.9 | 4.5 | 4.9 | 4.4 | 7.4 | 6.5 | 5.2 | 4.6 | 6.0 | 4.8 |
Dividends and splits
Per share, in the currency the company pays
Paid for 36 years. Last went ex-dividend on 18 May 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 | FY2017 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.71 | 1.30 | 1.23 | 1.17 | 1.12 | 1.08 | 1.97 | 0.88 |
- 4-for-1 split · 18 Apr 2005
- 2-for-1 split · 19 Feb 2001
- 1-to-1 reverse split · 1 Feb 2001
- 1-to-1 reverse split · 8 Jan 2001
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.